Ketamine Nasal Spray Helps Ease Depression in Mere Hours
Esketamine recently passed a phase-two clinical trial with flying colors, demonstrating its therapeutic uses for suicidal depression. The effects of esketamine occur in just four hours after treatment — an unheard-of length of time compared to conventional antidepressants such as Prozac and Paxil